Researchers will conduct a clinical trial investigating the safety and anticancer effectiveness of trametinib, a drug to treat companion dogs with aggressive cancers.
Researchers will develop innovative tools to study dilated cardiomyopathy, a common cause of heart failure, in Doberman pinschers, a high at-risk breed.